Effects of Low Dose Metformin on Metabolic Traits in Clozapine-Treated Schizophrenia Patients: An Exploratory Twelve-Week Randomized, Double-Blind, Placebo-Controlled Study

BACKGROUND: Metformin has been used for alleviating metabolic abnormalities in patients with schizophrenia. The lowest dose of metformin to treat metabolic abnormalities in clozapine-treated patients is 1000 mg/d. This study was designed to determine whether metformin at 500 mg/d and 1000 mg/d is ef...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:PLoS One
Main Authors: Chiu, Chih-Chiang, Lu, Mong-Liang, Huang, Ming-Chyi, Chen, Po-Yu, Lin, Yen-Kuang, Lin, Shih-Ku, Chen, Chun-Hsin
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2016
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5156367/
https://ncbi.nlm.nih.gov/pubmed/27973619
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0168347
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados